STC1 and breast cancer: IHC evaluation of breast cancer specimens demonstrated that a high expression of STC1 was negatively correlated with recurrence-free survival in breast cancer, indicating that STC1 expression could be used as a predictive marker for a poor prognosis in breast cancer.